Table 3.

Factors associated with AI versus tamoxifen use in multivariate logistic regression analysis (n = 1,379)^a

	OR	95% CI	P value
Age (years)			< 0.01
65 – 69	1.00
70 – 74	0.52	0.38 – 0.72	< 0.01
75 – 79	0.57	0.40 – 0.80	< 0.01
80 – 89	0.43	0.28 – 0.66	< 0.01
Race/Ethnicity			0.66
Non-Hispanic white	1.00
Other	1.10	0.72 – 1.70
Marital Status			0.44
Married	1.00
Widowed	0.88	0.66 – 1.17	0.39
Divorced	1.08	0.68 – 1.73	0.74
Never Married	0.66	0.37 – 1.19	0.17
Geographic Location			0.12
California	1.00
Florida	1.23	0.89 – 1.69	0.21
Illinois	1.09	0.76 – 1.56	0.62
New York	1.52	1.06 – 2.18	0.02
Educational Level			0.60
< High school	1.00
High school graduate	0.78	0.46 – 1.31	0.34
> High school	0.84	0.50 – 1.41	0.51
Annual Income ($)			0.23
15,000 or less	1.00
15,001 – 25,000	1.23	0.80 – 1.89	0.33
25,001 – 50,000	1.39	0.91 – 2.14	0.13
More than 50,000	1.65	1.02 – 2.67	0.04
Missing	1.13	0.72 – 1.78	0.61
Medication Coverage			< 0.01
None of the cost	1.00
Some of the cost	1.58	1.13 – 2.22	< 0.01
Almost all to all of the cost	1.66	1.20 – 2.30	< 0.01
Tangible Social Support			0.08
< 4.0 (least)	1.00
4.0 – 5.0 (most)	0.77	0.58 – 1.03
Emotional/Informational Support			< 0.01
< 3.5 (least)	1.00
3.5 – 5.0 (most)	1.58	1.19 – 2.10

Abbreviations: AI, aromatase inhibitor; CI, confidence interval; OR, odds ratio

^aExcludes 92 patients with missing information in any variable except income.